Alpha 2.0
Login Register
» Articles » PMID: 27765164

Drug Survival Analysis Is Not a Good Method for Assessing the Safety or Effectiveness of Systemic Therapies in Psoriasis

Overview
Journal Actas Dermosifiliogr
Specialty Dermatology
Date 2016 Oct 22
PMID 27765164
Citations 4
Authors
P Davila-Seijo
I Garcia-Doval
Affiliations
Soon will be listed here.
Citing Articles

Polymorphism in Gene for ABCC2 Transporter Predicts Methotrexate Drug Survival in Patients with Psoriasis.

Grzelj J, Marovt M, Marko P, Mlinaric-Rascan I, Gmeiner T, Smid A Medicina (Kaunas). 2021; 57(10).

PMID: 34684087 PMC: 8539794. DOI: 10.3390/medicina57101050.

Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort.

Hernandez-Fernandez C, Carretero G, Rivera R, Ferrandiz C, Dauden E, de Cueva P Acta Derm Venereol. 2020; 101(1):adv00354.

PMID: 33269405 PMC: 9309850. DOI: 10.2340/00015555-3711.

Drug survival and reasons for drug discontinuation in palmoplantar pustulosis: a retrospective multicenter study.

Kromer C, Wilsmann-Theis D, Gerdes S, Philipp S, Schaarschmidt M, Schmieder A J Dtsch Dermatol Ges. 2019; 17(5):503-516.

PMID: 30994260 PMC: 6850581. DOI: 10.1111/ddg.13834.

Comparison of Drug Discontinuation, Effectiveness, and Safety Between Clinical Trial Eligible and Ineligible Patients in BADBIR.

Mason K, Barker J, Smith C, Hampton P, Lunt M, Mcelhone K JAMA Dermatol. 2018; 154(5):581-588.

PMID: 29590279 PMC: 5876819. DOI: 10.1001/jamadermatol.2018.0183.